1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: ERLANGEN-1490, EU-20232, NCT00053391
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: Other Protocol IDs: ERLANGEN-ONTAK, EU-20246, NCT00056134
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M991, NCI-G00-1837, NCI-T99-0102, NCT00006113, T99-0102
|
|
4.
|
Phase: Phase I Type: Treatment Status: Closed Age: Over 21 Sponsor: NCI Protocol IDs: UCSD-970976, NCI-G98-1477
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-01-C-0121, NCI-1035, NCT00020540, 1035
|
|
6.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000582397, BCM-H-11541, BCM-CLIMAT, NCT00609076
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 75 and under Sponsor: Other Protocol IDs: H6408-Leu Leu, NCT00058799
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: H11967, CLIPA, NCT00078520
|